In this episode of the NextGenVC podcast, hosts Jen Fang and Mike Hostetler are joined by Chris Garabedian, founder of Xontogeny and biopharma veteran, to discuss the transformative impact of early-stage biotech investment. Chris shares his journey from biotech corporate leadership to venture capital, emphasizing the importance of thoughtful drug development and the value of nurturing early-stage companies. He explains the inception of Xontogeny, its collaboration with Perceptive Advisors, and the unique venture incubation model they follow. Chris also highlights the essential qualities for success in biotech investing and offers insights for budding entrepreneurs and potential VCs alike.